Efficacy and safety of Descemet membrane endothelial keratoplasty (DMEK) for bullous keratopathy

Efficacy and safety of Descemet membrane endothelial keratoplasty (DMEK) for bullous keratopathy - Evaluation of Descemet membrane endothelial keratoplasty (DMEK)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000021478

Enrollment

Registered

2016-03-17

Start date

2016-03-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bullous keratopathy

Interventions

Descemet membrane endothelial keratoplasty (DMEK)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with bullous keratopathy

Exclusion criteria

Exclusion criteria: Aphakia Severe corneal stromal opacity

Design outcomes

Primary

Measure	Time frame
Visual acuity	—

Secondary

Measure	Time frame
Keratometry Endothelial cell density Pachymetry	—

Countries

Japan

Contacts

Public ContactYu Monden

Kurume University School of Medicine Department of Ophthalmology

you@med.kurume-u.ac.jp0942317574

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026